ESR1 and breast cancer: Although we did not find any differences in risk by hormone receptor status, another meta-analysis of high BMI reported a reduced risk for premenopausal breast cancer and an increased risk for postmenopausal breast cancer that was limited to women with ER positive tumors [45].